Vendor audit record

Bio Peptide

Website biopeptitech.com

Audit slug bio-peptide Audited Auditor agent-research-C

Grade CCaution — stale program

Recent activity: Zero COAs in the last 90 days; latest publication was 129 days ago. Score: C. Score: C (revised from B under recent-cadence-weighted rubric). Bio Peptide Technologies (biopeptitech.com) is a real, accessible peptide vendor — not a fabricated name. The website is professional (Trustpilot 3.3 stars / 7 reviews, ScamAdviser 'Likely Safe', 2-year-old domain registered Nov 2023, USA address in Huntington Beach, CA). The COA program is the strongest of the four vendors audited in this batch: ~30 COAs visible at /pages/coa, distinct batch numbers per dosage, primarily issued by a real ISO/IEC 17025 third-party lab (Vanguard Laboratory). Per the rubric this clears 'C — Performative' (volume is healthy, dating is recent enough) and approaches 'A'. Why not A: (1) Vanguard COAs are PDFs without QR/portal verification — researchers cannot cryptographically re-check individual results through a public lab portal as they could with Janoshik; (2) some COAs use an in-house 'V250321' prefix issued by Bio Peptide itself, mixing vendor-self-issued reports into the program (rubric red flag 'vendor-self-issued'); (3) the every-batch-tested claim isn't explicitly made — instead the vendor leans on WHO/GMP/ISO-9001 certification language. Net: 'B — Strong but partial: Public COAs from a named third-party lab, but missing one of: every-batch coverage, lab portal verification, or recency.' Caveat on identity ambiguity: 'Bio Peptide' is a generic enough phrase that Trustpilot also returns biopeptide.in (a separate Indian vendor) — peptidescore.com's 'Bio Peptide' profile is unambiguously the Huntington Beach, CA US vendor at biopeptitech.com (matches the location 'Huntington Beach, CA' on peptidescore.com).

The take

A credible COA program that has gone four months stale and quietly mixes vendor-self-issued reports into the third-party stack — needs a published cadence to climb back.

Bio Peptide Technologies built a real COA program and then stopped feeding it. The public index at biopeptitech.com/pages/coa lists roughly 30 reports with distinct per-dosage batch numbers, mostly issued by Vanguard Laboratory — a real third-party operation claiming ISO/IEC 17025 accreditation. That foundation is more substantive than most vendors offer. The problem is recency: the latest COA is dated 2025-12-31, 129 days before this audit, and the trailing-90-day count is zero. The rubric weights recent cadence above all else, and this program has gone past the quarterly floor. Two structural issues compound the staleness. First, the Vanguard COAs carry no QR code or portal lookup ID, so a third party cannot re-verify any individual result without contacting the lab directly — the audit trail breaks at the PDF. Second, a subset of reports use an in-house 'V250321' prefix issued by Bio Peptide itself rather than by Vanguard, which trips the vendor-self-issued red flag and dilutes the third-party story. The brand is two years old, the address is real (Huntington Beach, CA), and the WHO/GMP/ISO 9001 certification language is plausible — none of that substitutes for current, verifiable lab work.

  • Strength. A real ISO/IEC 17025 third-party lab (Vanguard) and 30 distinct per-dosage batch reports give this program a foundation most C-graded vendors don't have.
  • Concern. Zero COAs in the last 90 days, no QR/portal verification on the Vanguard PDFs, and an in-house 'V250321' series mixed into the index — the third-party story is currently fraying on three fronts.

COA program

Public COA page Yes
Total COAs found 30
Date range 2024-01-01 → 2025-12-31
Cadence 0 COAs in the last 90 days — latest publication was 129 days before audit.
"Every batch" claimed? No
Volume vs. claim Vendor publishes ~30+ COAs across the catalog with distinct batch numbers per product/dosage (e.g., AOD-9604 5mg lot 2603AFL0343.1219, Tirzepatide 10mg lot 2603AFL0343.1208, Tesamorelin 2mg/5mg/10mg as separate entries). Multiple dosage strengths are individually documented, indicating real per-SKU testing rather than a single boilerplate COA. However, the vendor does NOT explicitly claim 'every batch tested' on the about/our-company page — they cite WHO/GMP and ISO 9001:2008 certifications without explicit batch-coverage language. The volume + dating pattern is consistent with per-batch testing, even though the marketing claim is not made.

Issuing labs & verifiability

  • Vanguard (Vanguard Laboratory / Vanguard Peptide Labs) Unverifiable — Vanguard Laboratory (vanguardlaboratory.com) is a real third-party peptide testing lab claiming ISO/IEC 17025 accreditation with PhD chemists reviewing every result. It is the primary lab on Bio Peptide Technologies' COAs (used for BPC-157, PT-141, TB-500, IGF1-LR3, and most others). The lab is independently verifiable as an entity. However, Bio Peptide's COAs do not embed Vanguard QR codes or expose Vanguard portal lookup IDs, so individual COAs cannot be re-verified by a third party without contacting Vanguard directly.
  • Bio Peptide Technologies (in-house, V250321 prefix series) Unverifiable — Some COAs use a 'V250321' in-house report prefix issued by Bio Peptide Technologies itself rather than by Vanguard. Vendor-self-issued COAs are non-verifiable and trigger the 'vendor-self-issued' red flag where they substitute for third-party reports.

Authenticity

Bottle images match brand? Unknown / unable to verify
Bottle evidence Product pages show vials with labeling. The COA index does not embed bottle photographs alongside each COA, so the audit cannot directly compare a vial photo to the COA's product description. No mismatched-brand evidence was observed; no clear branded-bottle evidence was observed either.
COA template shared with other vendors? No

Red flags

vendor-self-issued

Domain history

Site accessible at audit time Yes
First Wayback snapshot 2024-04-19
Approximate domain age ~2 years 0 months — WHOIS creation 2023-11-21; first Wayback snapshot 2024-04-19. Audited brand identity is 'Bio Peptide Technologies' / 'Biopeptitech'.

Evidence trail